Trial Profile
The Multicenter, Randomized, Double Blind Phase 3 Clinical Trial to Compare Efficacy and Safety of Combination of Amlodipine and Losartan Compared to Amlodipine Monotherapy in Patients With Stage 2 Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Dec 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/losartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 28 Nov 2011 Results published in the World Wide Web [online].
- 28 Nov 2011 Results were reported in BMC Research Notes.
- 21 May 2010 New trial record